An article titled “How might the TPP impact Vietnamese pharma?” dtd Oct 29, 2015 (http://www.vir.com.vn/how-might-the-tpp-impact-vietnamese-pharma.html) explores how TPP might make the situations difficult for Vietnamese Pharma industry. The article mentions how the stricter Intellectual Property Rights protection clauses may delay the entrance of generic drugs in the Vietnamese market. The result would be higher cost of essential drugs in a country where insurance plans do not have a high reach and drug prices are a sensitive issue. Also, stricter rules regarding data exclusivity, patent linkage and lower patentability criteria would mean less access of data and formulae to generic drugs manufacturers leading to delay in development of generic drugs. What impact will this have on Vietnamese population? Will this be a rise for the insurance companies in Vietnam? Will this impact the Vietnam’s cost of living and consequently take away the benefits of Vietnam’s low costs?